Owner Merck Patent GmbH

Inventors Sirrenberg, Christian; Buchstaller, Hans-Peter; Eggenweiler, Hans-Michael; Wolf, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2007271504

PCT Pub. Number WO2008/003396

Priority 10 2006 030 479.9 01.07.06 DE

Filing date 18 June 2007

Wipo publication date 10 January 2008

Acceptance publication date 24 May 2012

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom